Cutler Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Cutler Group’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-300	Closed	-$11K	–	7980
2016 Q3	$11K	Buy	+300	New	+$3.35K	﹤0.01%	4177

Cutler Group's TBRA Position: Q4 2016 in Review

Cutler Group sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 300 shares — an estimated $11K sold.

Cutler Group first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $11K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Cutler Group reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Cutler Group sold 300 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $11K.
Cutler Group first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Cutler Group's Tobira Therapeutics, Inc. Common Stock position peaked at $11K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Cutler Group's 13F filing for Q4 2016, filed 12 Jan 2017.